These results could be attributed to late diagnosis and the low rate of prostate cancer screening programs in Burkina Faso, highlighting the high PSA levels at diagnosis obtained in our study (mean 642.12 ± 1153.42 ng/ml). This evidence concerns the gene KLK3 and prostate carcinoma.